Home Cart 0 Sign in  
X

[ CAS No. 83673-98-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 83673-98-7
Chemical Structure| 83673-98-7
Chemical Structure| 83673-98-7
Structure of 83673-98-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 83673-98-7 ]

Related Doc. of [ 83673-98-7 ]

Alternatived Products of [ 83673-98-7 ]

Product Details of [ 83673-98-7 ]

CAS No. :83673-98-7 MDL No. :MFCD02181057
Formula : C9H12N2O4S Boiling Point : -
Linear Structure Formula :- InChI Key :PIWSRJPUYPNQJE-UHFFFAOYSA-N
M.W : 244.27 Pubchem ID :1502051
Synonyms :

Calculated chemistry of [ 83673-98-7 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.44
Num. rotatable bonds : 5
Num. H-bond acceptors : 5.0
Num. H-bond donors : 2.0
Molar Refractivity : 59.32
TPSA : 116.76 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.58 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.59
Log Po/w (XLOGP3) : 1.71
Log Po/w (WLOGP) : 2.0
Log Po/w (MLOGP) : 0.33
Log Po/w (SILICOS-IT) : 1.27
Consensus Log Po/w : 1.38

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.33
Solubility : 1.13 mg/ml ; 0.00465 mol/l
Class : Soluble
Log S (Ali) : -3.78
Solubility : 0.0408 mg/ml ; 0.000167 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.63
Solubility : 5.78 mg/ml ; 0.0237 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.01

Safety of [ 83673-98-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 83673-98-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 83673-98-7 ]
  • Downstream synthetic route of [ 83673-98-7 ]

[ 83673-98-7 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 189512-01-4 ]
  • [ 83673-98-7 ]
YieldReaction ConditionsOperation in experiment
100% With water; potassium hydroxide In tetrahydrofuran at 20℃; for 2 h; General procedure: An aqueous KOH (10percent w/v) solution was added to an ester solution in THF. The reaction mixture was stirred at room temperature until reagent disappearance was confirmed by TLC. HCl 1 M was added until pH 4 and the solution was extracted with EtOAc.The organic layer was dried over MgSO4 and concentrated in vacuoto afford the acid.
94%
Stage #1: With lithium hydroxide In tetrahydrofuran; water
Stage #2: With hydrogenchloride In tetrahydrofuran; water
(2)
Lithium hydroxide monohydrate (20.16 g, 0.48 mol) was added to a stirred solution of 2-tert-butoxycarbonylamino-thiazole-4-carboxylic acid ethyl ester (52.35 g, 0.192 mol) in a mixture of tetrahydrofuran (800 mL) and water (200 mL).
The mixture was stirred over night. 1 N Aqueous hydrochloric acid (480 mL) was added and the reaction mixture concentrated in vacuo to remove tetrahydrofuran.
The mixture was then diluted with water and filtered.
The solid was washed with water, ether and dried overnight to give 2-tert-butoxycarbonylamino-thiazole-4-carboxylic acid (43.9 g, 94percent).
80.5% With water; sodium hydroxide In tetrahydrofuran; methanol at 20℃; for 3 h; A mixture of compound 2 (11.5 g, 42.3mmol), NaOH (3.4 g, 84.6 mol) and H2O (5 ml) in a mixture solvent of CH3OH (40 ml) and THF (40 ml), was stirred at room temperature for 3h. The solvent was evaporated in vacuo, the residue was dissolved with ethyl acetate (40 ml) and H2O (10ml), the separated aqueous layer was acidized with HCl (12 mol/L) to get white precipitate. The mixture was filtered and the filtered cake was washed with a small amount of H2O, dried in vacuo to give compound 3 as a white solid (8.3 g, yield 80.5percent).
Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 126, p. 776 - 788
[2] Patent: US2006/41146, 2006, A1, . Location in patent: Page/Page column 15
[3] Journal of the American Chemical Society, 2000, vol. 122, # 27, p. 6382 - 6394
[4] Chinese Chemical Letters, 2015, vol. 26, # 10, p. 1315 - 1318
[5] Patent: US2002/173490, 2002, A1,
[6] Patent: WO2007/51560, 2007, A1, . Location in patent: Page/Page column 34-35
[7] Patent: US6756360, 2004, B1, . Location in patent: Page column 150
[8] Patent: CN104650064, 2017, B, . Location in patent: Paragraph 0053; 0054; 0055
[9] Patent: WO2018/134254, 2018, A1, . Location in patent: Page/Page column 80; 81
[10] Patent: US6489476, 2002, B1,
  • 2
  • [ 850429-62-8 ]
  • [ 83673-98-7 ]
YieldReaction ConditionsOperation in experiment
76% With water; lithium hydroxide In tetrahydrofuran at 20℃; for 12 h; To a solution of methyl 2-[[(tert-butoxy)carbonyl]amino]-l,3-thiazole-4-carboxylate (28 g, 108 mmol) in tetrahydrofuran (300 mL) was added a solution of lithium hydroxide (10.4 g, 433 mmol) in water (150 mL). The resulting mixture was stirred for 12 h at room temperature. The pH of the solution was adjusted to 4 with hydrochloric acid (2 mol/L). The solids were collected by filtration to afford 2- [[(teri-butoxy)carbonyl]amino]-l,3-thiazole-4-carboxylic acid (20 g, 76percent) as an off-white solid. LCMS (ESI): M+H+ = 245.0.
71%
Stage #1: With lithium hydroxide In tetrahydrofuran; water at 20℃;
Stage #2: With hydrogenchloride In water
2-tert-Butoxycarbonylamino-thiazole-4-carboxylic acid methyl ester (15.5 g, 60.01 mmol) was dissolved in 4:1 tetrahydrofuran:water (300 mL) followed by the addition of lithium hydroxide monohydrate (5.29 g, 126.07 mmol). The solution was stirred overnight at room temperature. Tetrahydrofuran was removed under vacuum and the salt was neutralized with 2.0 N aqueous hydrochloric acid. The resulting precipitate was filtered and dried to give 2-tert-butoxycarbonylamino-thiazole-4-carboxylic acid (10.4 g, 71percent).
Reference: [1] Patent: WO2015/52226, 2015, A1, . Location in patent: Paragraph 0488
[2] Patent: US2006/63814, 2006, A1, . Location in patent: Page/Page column 61
  • 3
  • [ 24424-99-5 ]
  • [ 83673-98-7 ]
Reference: [1] Journal of the American Chemical Society, 2000, vol. 122, # 27, p. 6382 - 6394
[2] Patent: WO2015/52226, 2015, A1,
[3] Chinese Chemical Letters, 2015, vol. 26, # 10, p. 1315 - 1318
[4] European Journal of Medicinal Chemistry, 2017, vol. 126, p. 776 - 788
[5] Patent: WO2018/134254, 2018, A1,
[6] Patent: US6489476, 2002, B1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 83673-98-7 ]

Amides

Chemical Structure| 494769-44-7

[ 494769-44-7 ]

tert-Butyl (4-(hydroxymethyl)thiazol-2-yl)carbamate

Similarity: 0.91

Chemical Structure| 914349-71-6

[ 914349-71-6 ]

Methyl 5-bromo-2-((tert-butoxycarbonyl)amino)thiazole-4-carboxylate

Similarity: 0.85

Chemical Structure| 668484-45-5

[ 668484-45-5 ]

2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)thiazole-4-carboxylic acid

Similarity: 0.84

Chemical Structure| 1001419-35-7

[ 1001419-35-7 ]

tert-Butyl (4-(bromomethyl)thiazol-2-yl)carbamate

Similarity: 0.80

Chemical Structure| 867065-53-0

[ 867065-53-0 ]

Ethyl 2-(4-(tert-butoxycarbonyl)piperazin-1-yl)thiazole-4-carboxylate

Similarity: 0.80

Amines

Chemical Structure| 494769-44-7

[ 494769-44-7 ]

tert-Butyl (4-(hydroxymethyl)thiazol-2-yl)carbamate

Similarity: 0.91

Chemical Structure| 914349-71-6

[ 914349-71-6 ]

Methyl 5-bromo-2-((tert-butoxycarbonyl)amino)thiazole-4-carboxylate

Similarity: 0.85

Chemical Structure| 1001419-35-7

[ 1001419-35-7 ]

tert-Butyl (4-(bromomethyl)thiazol-2-yl)carbamate

Similarity: 0.80

Chemical Structure| 1210278-19-5

[ 1210278-19-5 ]

N-Boc-2-Amino-4-cyanothiazole

Similarity: 0.80

Chemical Structure| 170961-15-6

[ 170961-15-6 ]

tert-Butyl thiazol-2-ylcarbamate

Similarity: 0.76

Carboxylic Acids

Chemical Structure| 668484-45-5

[ 668484-45-5 ]

2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)thiazole-4-carboxylic acid

Similarity: 0.84

Chemical Structure| 86978-24-7

[ 86978-24-7 ]

(Z)-2-(2-((tert-Butoxycarbonyl)amino)thiazol-4-yl)pent-2-enoic acid

Similarity: 0.73

Chemical Structure| 302964-02-9

[ 302964-02-9 ]

2-Boc-Aminothiazole-5-carboxylic acid

Similarity: 0.71

Chemical Structure| 952182-68-2

[ 952182-68-2 ]

2-(Piperidin-1-yl)thiazole-4-carboxylic acid

Similarity: 0.69

Chemical Structure| 115065-79-7

[ 115065-79-7 ]

2-(2-(((Benzyloxy)carbonyl)amino)thiazol-4-yl)-5-((3-methylbut-2-en-1-yl)oxy)-5-oxopent-2-enoic acid

Similarity: 0.68

Related Parent Nucleus of
[ 83673-98-7 ]

Thiazoles

Chemical Structure| 494769-44-7

[ 494769-44-7 ]

tert-Butyl (4-(hydroxymethyl)thiazol-2-yl)carbamate

Similarity: 0.91

Chemical Structure| 914349-71-6

[ 914349-71-6 ]

Methyl 5-bromo-2-((tert-butoxycarbonyl)amino)thiazole-4-carboxylate

Similarity: 0.85

Chemical Structure| 668484-45-5

[ 668484-45-5 ]

2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)thiazole-4-carboxylic acid

Similarity: 0.84

Chemical Structure| 1001419-35-7

[ 1001419-35-7 ]

tert-Butyl (4-(bromomethyl)thiazol-2-yl)carbamate

Similarity: 0.80

Chemical Structure| 867065-53-0

[ 867065-53-0 ]

Ethyl 2-(4-(tert-butoxycarbonyl)piperazin-1-yl)thiazole-4-carboxylate

Similarity: 0.80